Advertisement
OrganiGram Holdings Inc.

OrganiGram Holdings Inc. Fundamental Analysis

OGI.TOTSX
HealthcareDrug Manufacturers - Specialty & Generic
$1.38
$0.00(0.00%)
Canadian Market is Open · 09:44
Advertisement

OrganiGram Holdings Inc. Fundamental Analysis

OrganiGram Holdings Inc. (OGI.TO) shows weak financial fundamentals with a PE ratio of -7.25, profit margin of -9.19%, and ROE of -6.83%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position30.16%
PEG Ratio-0.01
Current Ratio2.82

Areas of Concern

ROE-6.83%
Operating Margin-38.62%
We analyze OGI.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 19.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
19.8/100

We analyze OGI.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

OGI.TO struggles to generate sufficient returns from assets.

ROA > 10%
-4.84%

Valuation Score

Excellent

OGI.TO trades at attractive valuation levels.

PE < 25
-7.25
PEG Ratio < 2
-0.01

Growth Score

Weak

OGI.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

OGI.TO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
2.82

Profitability Score

Weak

OGI.TO struggles to sustain strong margins.

ROE > 15%
-683.25%
Net Margin ≥ 15%
-9.19%
Positive Free Cash Flow
No

Key Financial Metrics

Is OGI.TO Expensive or Cheap?

P/E Ratio

OGI.TO trades at -7.25 times earnings. This suggests potential undervaluation.

-7.25

PEG Ratio

When adjusting for growth, OGI.TO's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values OrganiGram Holdings Inc. at 0.49 times its book value. This may indicate undervaluation.

0.49

EV/EBITDA

Enterprise value stands at -5.76 times EBITDA. This is generally considered low.

-5.76

How Well Does OGI.TO Make Money?

Net Profit Margin

For every $100 in sales, OrganiGram Holdings Inc. keeps $-9.19 as profit after all expenses.

-9.19%

Operating Margin

Core operations generate -38.62 in profit for every $100 in revenue, before interest and taxes.

-38.62%

ROE

Management delivers $-6.83 in profit for every $100 of shareholder equity.

-6.83%

ROA

OrganiGram Holdings Inc. generates $-4.84 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.84%

Following the Money - Real Cash Generation

Operating Cash Flow

OrganiGram Holdings Inc. generates limited operating cash flow of $-9.34M, signaling weaker underlying cash strength.

$-9.34M

Free Cash Flow

OrganiGram Holdings Inc. generates weak or negative free cash flow of $-20.95M, restricting financial flexibility.

$-20.95M

FCF Per Share

Each share generates $-0.15 in free cash annually.

$-0.15

FCF Yield

OGI.TO converts -10.65% of its market value into free cash.

-10.65%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-7.25

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.49

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.69

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.82

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.07

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

-0.24

vs 25 benchmark

How OGI.TO Stacks Against Its Sector Peers

MetricOGI.TO ValueSector AveragePerformance
P/E Ratio-7.2533.74 Better (Cheaper)
ROE-6.83%404.00% Weak
Net Margin-9.19%-40219.00% (disorted) Weak
Debt/Equity0.020.81 Strong (Low Leverage)
Current Ratio2.825.53 Strong Liquidity
ROA-4.84%-281.00% (disorted) Weak

OGI.TO outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews OrganiGram Holdings Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ